Affordable Access

Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.

Authors
  • Goldsmith, Christy
  • Gaya, Andrew
Type
Published Article
Journal
Cancer imaging : the official publication of the International Cancer Imaging Society
Publication Date
Jan 01, 2012
Volume
12
Pages
351–360
Identifiers
PMID: 23023165
Source
Medline
License
Unknown

Abstract

Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment of primary and secondary lung tumours is appraised, and key ongoing trials are identified.

Report this publication

Statistics

Seen <100 times